The regenerative medicine company T&R Biofab announced on the 2nd that its polyurethane (PU) foam formulation wound dressing product line has obtained approval from the Ministry of Food and Drug Safety.
The products that obtained approval this time are named Reprofoam and Bonofoam, which the company described as maximising
the advantages of the polyurethane material.
The polyurethane material effectively maintains a moist environment, absorbs exudate (blood from a wound), and helps prevent wound contamination. It aids faster wound healing compared to dry dressing gauze. It can be easily used on the delicate skin of children and the sensitive skin of the elderly, thanks to the use of silicone adhesive. At a thickness of 0.5mm, it is very thin, providing excellent skin adhesion and ease of use on curved areas.
Previously, the company received approval for functional foam band and drug-containing foam band products, and this latest approval has expanded its commercially available wound dressing product line.
Jeong Seung-kyo, executive director of institutional sector planning at T&R Biofab, noted, "Sales of medical products specialized in regenerative medicine, including foam formulation wound dressings, ointment-type wound dressings, and hemostatic agents, are expected to increase significantly," adding, "This sector's sales are predicted to account for more than 30% of the company's total expected sales of 30 billion won this year."
Executive Jeong stated, "We will intensify our entry into the Chinese market for ointment-type wound dressings," and added, "We expect the approval of neurosurgery-related products such as craniofacial implants (CFI) from the U.S. Food and Drug Administration (FDA) within this year, which will accelerate the growth of the medical sector."
In the interim, T&R Biofab is anticipating that its vascular-derived extracellular matrix (VdECM) haemostatic agent product will be approved within the first quarter of this year. This absorbable composite haemostatic agent is employed to maintain haemostasis in internal tissues and vascular systems during surgical procedures. It is capable of promoting the regeneration and healing of damaged tissues through its VdECM components, in addition to haemostasis and adhesion prevention.
Source: CHOSUNBIZ.
Comments